Login / Signup

Fetal hydrops caused by a novel pathogenic MECOM variant.

Elizabeth WallJoan ForsythEsther KinningTamás Marton
Published in: Prenatal diagnosis (2023)
We report a fetus with hydrops, congenital heart disease and bilateral radioulnar synostosis caused by a novel pathogenic MECOM variant. The female fetus was referred for post-mortem examination after fetal hydrops and intrauterine death was diagnosed at 20 weeks gestation. Post-mortem examination confirmed fetal hydrops, pallor, truncus arteriosus and bilateral radioulnar synostosis. Trio whole genome sequencing analysis detected a novel de novo heterozygous pathogenic loss-of-function variant in MECOM (NM_004991), associated with a diagnosis of Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia 2 (RUSAT-2). RUSAT-2 is a variable condition associated postnatally with bone marrow failure, radioulnar synostosis and congenital anomalies. RUSAT-2 is not currently associated with a prenatal phenotype or fetal demise, and was not present on diagnostic NHS prenatal gene panels at time of diagnosis. This case highlights the diagnostic value of detailed phenotyping with post-mortem examination, and of using a broad sequencing approach.
Keyphrases
  • congenital heart disease
  • bone marrow
  • pregnant women
  • preterm infants
  • mesenchymal stem cells
  • photodynamic therapy
  • case report
  • genome wide
  • early onset
  • high throughput
  • copy number